Sagar, R;
Almeida-Porada, G;
Blakemore, K;
Chan, JKY;
Choolani, M;
Götherström, C;
Jaulent, A;
... David, AL; + view all
(2020)
Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement.
Molecular Therapy
, 28
(11)
pp. 2316-2319.
10.1016/j.ymthe.2020.10.012.
Preview |
Text
David_iFeTiS consensus statement rev 9 Oct 2020 no track.pdf - Accepted Version Download (625kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ymthe.2020.10.012 |
| Publisher version: | https://doi.org/10.1016/j.ymthe.2020.10.012 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | in utero stem cell transplantation; fetal therapy; adverse event; clinical trial; maternal; fetal; safety; |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health > Maternal and Fetal Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10114409 |
Archive Staff Only
 |
View Item |
